Regional and systemic prophylaxis with teicoplanin in total knee arthroplasty: A tissue penetration study

Journal of Arthroplasty

Volumn 18, Issue 3, 2003, Pages 342-346

  Lazzarini, Luca ^a   Novelli, Andrea ^b   Marzano, Nicola ^c   Timillero, Lia ^a   Fallani, Stefania ^b   Viola, Renato ^c   De Lalla, Fausto ^a  

^a SAN BORTOLO HOSPITAL   (Italy)

^b UNIVERSITY OF FLORENCE   (Italy)

^c SS Giovanni e Paolo Hospital   (Italy)

Author keywords

Antibiotics; Arthroplasty; Infection; Orthopaedic surgery; Prophylaxis; Teicoplanin

Indexed keywords

TEICOPLANIN;

ADULT; AGED; ANTIBIOTIC PROPHYLAXIS; ARTHROPLASTY; ARTICLE; CLINICAL ARTICLE; COAGULASE NEGATIVE STAPHYLOCOCCUS; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG EFFICACY; DRUG PENETRATION; DRUG SAFETY; DRUG TISSUE LEVEL; FEMALE; FOLLOW UP; HUMAN; INFECTION; MALE; ORTHOPEDIC SURGERY; POSTOPERATIVE INFECTION; POSTOPERATIVE PERIOD; SIDE EFFECT; TOTAL KNEE REPLACEMENT; TOURNIQUET;

EID: 0038643491     PISSN: 08835403     EISSN: None     Source Type: Journal    
DOI: 10.1054/arth.2003.50053     Document Type: Article

References (19)

1. Brause BD: Infected orthopedic prostheses. p. 111. In Bisno AF, Waldvogel FA (eds): Infections associated with indwelling medical devices. American Society for Microbiology: Washington, DC, 1989
2. Gorbach SL, Condon RE, Conte JE Jr., Kaiser AB, et al: General guidelines for the evaluation of new antiinfective drugs for prophylaxis of surgical infections: evaluations of new anti-infective drugs for surgical prophylaxis. Clin Infect Dis 15(suppl 1):S313, 1992
3. Gillespie WJ: Prevention and management of infection after total joint replacement. Clin Infect Dis 25:1310, 1997
4. Peersman G, Laskin R, Davis J, Peterson M: Infection in total knee replacement: a retrospective review of 6489 total knee replacements. Clin Orthop 392:15, 2001
5. Greenwood C: Microbiological properties of teicoplanin. J Antimicrob Chemother 21:1, 1988
6. Wilson APR, Taylor B, Treasure T, et al: Antibiotic prophylaxis in cardiac surgery: serum and tissue levels of teicoplanin, flucloxacillin, and tobramycin. J Antimicrob Chemother 21:201, 1988
7. Hoddinott C, Lovering AM, Fernando HC, et al: Determination of bone and fat concentrations following systemic cefamandole and regional cefuroxime administration in patients undergoing knee arthroplasty. J Antimicrob Chemother 26:823, 1990
8. de Lalla F, Novelli A, Pellizzer GP, et al: Regional and systemic propylaxis with teicoplanin in monolateral and bilateral total knee replacement procedures: study of pharnacokinetics and tissue penetration. Antimicrob Agents Chemother 37:2693, 1993
9. Nehrer S, Thalhammer F, Schwameis E, et al: Teicoplanin in the prevention of infection in total hip replacement. Arch Orthop Surg 118:32, 1998
10. Ivey FM, Hicks CA, Calhoun JH, Mader JT: Treatment options for infected knee arthroplasties: clinical reports. Rev Infect Dis 12:468, 1990
11. Segawa H, Tsukayama DT, Kyle RF, et al: Infection after total knee arthroplasty: a retrospective study of the treatment of eighty-one infections. J Bone Joint Surg Am 81:1434, 1999
12. de Lalla F: Surgical prophylaxis in practice. J Hosp Infect 50(Suppl A):S1, 2002
13. Arciola CR, Cervellati M, Pirini V, et al: Staphylococci in orthopaedic surgical wounds. New Microbiol 24:365, 2001
14. Periti P, Mini E, Grassi F, Cherubino P: Profilassi antimicrobica della infezione chirurgica in ortopedia: Risultati dell'indagine epidemiologica promossa per l'Italia dal Journal of Chemotherapy. J Chemother 12(Suppl 2):28, 2000
15. Lazzarini L, Pellizzer G, Stecca C, et al: Postoperative infections following total knee replacement: an epidemiological study. J Chemother 13:182, 2001
16. Periti P, Stringa G, Mini E, and the Italian Study Group for Antimicrobial Prophylaxis in Orthopedic Surgery: comparative multicenter trial of teicoplanin versus cefazolin for antimicrobial prophylaxis in prosthetic joint implant surgery. Eur J Clin Microbiol Infect Dis 18:113, 1999
17. Recommendations for preventing the spread of vancomycin resistance: recommendations of the Hospital Infection Control Practices Advisory Committee (HICPAC). Morb Mortal Wkly Rep 4:1, 1995
18. Biavasco F, Vignaroli C, Varaldo PE: Glycopeptide resistance in coagulase negative staphylococci. Eur J Clin Microbiol Infect Dis 19:403, 2000
19. de Lalla F, Viola R, Pellizzer GP, et al: Regional prophylaxis with teicoplanin in monolateral or bilateral total knee replacement: an open study. Antimicrob Agents Chemother 44:316, 2000